#InformaticsInsider (Volume 3)

Welcome to the third edition of the?#InformaticsInsider?!Your go-to source for all the latest developments, trends, and insights in the world of Bioinformatics and life science software.

Whether you're a Bioinformatics professional, a researcher, or just have a passion for all things biotech, Informatics Insider is here to provide you with the knowledge and expertise you need to stay ahead of the curve. In each issue, we'll bring you the latest news from the world of Bioinformatics and Life Science Software.

If you're interested in contributing to an upcoming edition or collaborating on a future project, please don't hesitate to reach out. As ever I'd love to hear from you!

Company of the week

This weeks company of the week is Seqera . They launched as an open-source software project in 2013 to develop the Nextflow programming language for scientific data analysis, Seqera now have bases in Barcelona and Toronto with a user base of 8000 researchers globally accessing the NextFlow Tower, an intuitive command post allowing secure and collaborative working on genomic data analysis at scale.

With the likes of AstraZeneca, Janssen Pharmaceuticals, Oxford Nanopore, and Invitae amongst their users and researchers, Seqera Labs have earned the trust and respect of giants in the sector, and are quickly emerging as a household name in life sciences research. Customer applications of Nextflow range from personalised immunogenic vaccines to new pandemic diagnostics, genetic surveillance, and genetically-targeted treatments helping usher in a new era of personalised medicine.

Seqera now have bases in Barcelona and Toronto with a user base of 8000 researchers globally and more than 150 leading pharma and biotech firms accessing the Nextflow Tower, an intuitive command post allowing secure and collaborative working on genomic data analysis at scale.

Seqera also featured heavily in an article I recently wrote on "Bioinformatic Start-ups taking the Lead"

if you haven't already already check it out on the link below!!!!!

https://www.searchinglifescience.com/media/1248/bioinformatic-start-ups-taking-the-lead

Collaboration of week

Microba Life Sciences X Mainz Biomed

Mainz Biomed is a molecular genetics diagnostic company specialising in the early detection of cancer, announced today a research collaboration with Microba Life Sciences (ASX: MAP) (“Microba”), a precision microbiome company leveraging a world-leading technology platform for measuring the human gut microbiome to discover and develop novel therapeutics for major diseases. As part of the agreement, Microba and Mainz Biomed will conduct a pilot research project utilizing Microba’s proprietary metagenomic sequencing technology and bioinformatic tools to potentially discover novel microbiome biomarkers for pancreatic cancer detection.

The project is expected to run through late 2023 and will deploy Microba’s Community Profiler (MCP), Microba’s unique metagenomic platform technology. MCP has been established as a best-in-class research tool with the ability to produce comprehensive and accurate species profiles of human gastrointestinal samples. Mainz Biomed is currently commercializing its flagship product ColoAlert?, a highly efficacious and easy-to-use detection test for colorectal cancer.

Luke Reid Guido Baechler

Candidate of the week

VP/Director Bioinformatics-20+ years of experience

• NGS data analysis, building pipeline, and developing tools.
• Managed 3 teams of 12 bioinformatics scientists ranging in levels.
• High throughput data analysis and develop tools for next generation sequencing – RNA/DNA/Epigenome sequencing and tiling array.
• CAP/CLIA LDT validated pipelines for two sequencing assays.
• Identify and guide the development of product features and service capabilities to address emerging customer needs in translational research.
• Computational & system biology, Artificial Intelligence & Machine Learning

?PhD – Bioinformatics?

If you have any interest in the profile above, don't hesitate to reach out, I'd be happy to make an introduction!!

Informatics news

• SOPHiA GENETICS Q1 revenues grows 28% on strong data analytics sales.
• 赛默飞世尔科技 and 辉瑞 partner to bring NGS based cancer tests to underserved markets.
• Singular Genomics Q1 grow sequentially.
• bioMérieux gets CLIA waiver for BioFire SpotFire respiratory mini.
• Euformatics inks distribution deal with Zahrawi Group for Bahrain, Oman and the UAE.
• Invivoscribe leukaemia CDx assay nabs IVDR approval.
• Applied BioCode, Inc. inks US distribution deal with Medline Industries, LP for MDx system, test menu.

Do you have any thoughts, or news to share? Join the conversation on LinkedIn by following the hashtag?#InsiderInformatics.

If you're looking to add exceptional talent to your team or seeking new opportunities in the industry, please feel free to reach out to me.